Restoring host antitumoral immunity: How coregulatory molecules are changing the approach to the management of renal cell carcinoma

Brant A. Inman, Xavier Frigola, Haidong Dong, James C. Yang, Eugene D. Kwon

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Renal cell carcinoma (RCC) is a tumor whose past is filled with failed treatments and unpreventable patient death. Fortunately, science is progressing at an ever increasing rate and novel discoveries are bringing new possibilities for patients with RCC. The future of RCC treatment is bright, and we believe that immunotherapy will realize much of its potential within the next decade. In this chapter, we discuss one of the newest discoveries in RCC tumor immunology: T-cell coinhibition. This chapter will first introduce key concepts of T-cell function and tumor immunology that are necessary for a good understanding of how coinhibition works. We then describe some of the key defects in immunity that are present in RCC. Finally, we propose a model to explain why certain renal tumors are eliminated by the immune system and others are not.

Original languageEnglish (US)
Title of host publicationRenal Cell Carcinoma
Subtitle of host publicationMolecular Targets and Clinical Applications
PublisherHumana Press
Pages367-403
Number of pages37
ISBN (Print)9781588297372
DOIs
StatePublished - Dec 1 2009

Keywords

  • Coinhibition
  • Costimulation
  • Immunoediting
  • Immunotherapy
  • Renal cell carcinoma
  • T lymphocyte
  • Tumor immunology

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Restoring host antitumoral immunity: How coregulatory molecules are changing the approach to the management of renal cell carcinoma'. Together they form a unique fingerprint.

  • Cite this

    Inman, B. A., Frigola, X., Dong, H., Yang, J. C., & Kwon, E. D. (2009). Restoring host antitumoral immunity: How coregulatory molecules are changing the approach to the management of renal cell carcinoma. In Renal Cell Carcinoma: Molecular Targets and Clinical Applications (pp. 367-403). Humana Press. https://doi.org/10.1007/978-1-59745-332-5_21